Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
9.95
-0.21 (-2.12%)
At close: Jun 26, 2026, 4:00 PM EDT
10.00
+0.05 (0.55%)
After-hours: Jun 26, 2026, 4:00 PM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $397.8 million as of June 26, 2026. Its market cap has increased by 586.65% in one year.
Market Cap
397.80M
Enterprise Value
401.42M
1-Year Change
586.65%
Ranking
Category
Stock Price
$9.95
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $397.80M, a decrease of -28.13%. That is a compound annual growth rate of -11.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 397.80M | 659.19% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 466.60M |
| Shattuck Labs | 460.85M |
| Forte Biosciences | 453.04M |
| Artiva Biotherapeutics | 452.84M |
| vTv Therapeutics | 443.52M |
| Silence Therapeutics | 432.66M |
| Editas Medicine | 429.69M |
| Sagimet Biosciences | 427.94M |